Industry News

Global Fluoroscopy Equipment Market to Top USD3.5 Billion by 2031 Due to Demand for Multipurpose Imaging Tools

By Medimaging International staff writers
29 Nov 2021


The global fluoroscopy equipment market is projected to grow at a CAGR of 6% from an estimated USD 1.9 billion in 2021 to surpass USD 3.5 billion by the end of 2031, driven by surging applications of fluoroscopy equipment across various medical fields such as cardiology, nephrology, urology, and others.

These are the latest findings of Fact.MR (Rockville, MD, USA), a market research and competitive intelligence provider.

Increasing adoption of multipurpose medical imaging tools such as fluoroscopy systems for real-time diagnosis, injury assessment, and during surgical procedures such as gastrointestinal, cardiovascular, and neurosurgeries is favoring the demand. Fluoroscopy equipment application is increasing across a wide range of interventional radiological procedures and treatment of conditions such as pulmonary embolism, abdominal aortic aneurysms, deep vein thrombosis, and others. In addition to this, increasing use of radiographic fluoroscopy in pain management and radiation therapy for cancer treatment is anticipated to create attractive growth opportunities for the fluoroscopy equipment market.

The growing incidence of chronic diseases and rising consumer preference for minimally invasive surgeries across most parts of the world are propelling the demand for fluoroscopy devices. The increasing use of fluoroscopy equipment in image-guided cardiovascular surgeries and the growing burden of cardiovascular diseases across the world are driving sales across the cardiology segment. However, the high risk of complications such as underlying tissue injuries and radiation-induced skin during radiographic fluoroscopy procedures is hampering the demand for fluoroscopy equipment. Moreover, the increasing inclination towards non-radiation imaging modalities such as ultrasound is a primary factor hindering the sales of fluoroscopy equipment.

On the basis on product type, the C-arms systems segment is estimated to account for nearly 40% of the global fluoroscopy equipment market and record a 1.7X sales growth through 2031. The increasing use of C-arms systems in discography, angiography, and image-guided surgeries is primarily driving the segment’s growth. The market for conventional fluoroscopy systems is also expected to grow at a CAGR of over 4% during the forecast period. Remote-controlled fluoroscopy systems market will also witness significant growth.

Leading players are focusing on product development initiatives to launch novel systems with integrated innovative tools to gain a competitive advantage. Strategic collaborations, partnerships, merger, and are some of the most adopted strategies in the industry. Geographically, the US is estimated to witness the fastest growth in the North American fluoroscopy equipment market, expanding by 1.5X over the assessment period. Germany is projected to emerge as one of the highly remunerative markets in Europe, creating absolute dollar opportunity of more than USD 400 million by 2031. Japan is forecasted to account for a high share of the Asia Pacific market for fluoroscopy equipment and grow at a CAGR of 3% through 2031. China is anticipated to emerge as one of the highly lucrative markets for fluoroscopy equipment, backed by the government’s push to the expansion and modernization of healthcare infrastructure.

Related Links:

E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

21 Jan 2022
Global Immunofluorescence Assay (IFA) Market to Surpass USD 4 Billion by 2028 Due to Growing Burden of Infectious Diseases
The global immunofluorescence assay (IFA) market is expected to reach USD 4.01 billion by 2028, driven by the increasing global healthcare burden of chronic and infectious diseases, rising application of immunofluorescence assays in clinical diagnostics and research, and growing investments and expenditure in healthcare sector.
Read More
21 Jan 2022
Global Digital X-Ray Systems Market to Be Driven by AI-Based Systems and Robotic Devices
The global digital X-ray systems market was valued at USD 11.74 billion in 2020 and is expected to grow at a CAGR of 7.45% during the forecast period 2021 to 2026, due to the rising number of cancer patients and increasing cases of orthopedic diseases/tumors, cardiovascular diseases (CVD), pneumonia, and dental disorders, among others.
Read More
20 Jan 2022
Illumina and Boehringer Ingelheim Partner to Develop Companion Diagnostics (CDx) for Cancer Treatment
Illumina Inc. (San Diego, CA, USA) has entered into a partnership with Boehringer Ingelheim (Ingelheim am Rhein, Germany; to develop companion diagnostics (CDx) for several programs in the latter’s oncology pipeline. The partnership aims to accelerate the development of therapy selection and precision medicines for patients with advanced cancer.
Read More
20 Jan 2022
Thermo Fisher and Oncocyte to Jointly Develop IVD Test Kits and Companion Diagnostic Tests in Precision Oncology
Oncocyte Corporation (Irvine, CA, USA) has entered into a development and co-marketing agreement for two distributed in vitro diagnostic (IVD) assays on Thermo Fisher Scientific’s (Waltham, MA, USA) Ion Torrent Genexus System. The agreement also grants Oncocyte rights to develop future companion diagnostics on the Genexus System.
Read More
18 Jan 2022
Global Coagulation Analyzers Market Driven by Growing Awareness About Timely Diagnosis of Blood Clots
The global coagulation analyzers market is expected to reach USD 11.7 billion by 2028, driven by the increasing understanding of blood clots and the fact that they can be avoided with early detection.
Read More
17 Jan 2022
Mobile C-Arms Market to Surpass USD 1.6 Billion in 2027 Due to Growing Preference for Minimally Invasive Surgeries
The global mobile C-arms market is expected to grow at a CAGR of 5.2% from USD 1.07 billion in 2019 to USD 1.61 billion in 2027, driven primarily by an increase in the global geriatric population, rising burden of chronic and acute diseases across the world, increasing volumes of orthopedic, cardiac, neurological, and oncological surgical procedures, and growing preference for minimally invasive surgeries.
Read More
14 Jan 2022
Medlab Middle East to Reveal Latest Innovations and Technologies in Mobile Labs for COVID-19 Testing
The latest technology and innovation in the global fight against COVID-19 and beyond will be on show at the next edition of Medlab Middle East when it returns to the Dubai World Trade Center from 24-27 January 2022 with mobile molecular testing and diagnosis stations, or ‘laboratories on wheels’, from companies such as Seegene, Inc. (Seoul, Korea) taking center stage.
Read More
13 Jan 2022
Global Coagulometers Market to Be Driven by Rising Prevalence of Blood Disorders
The global coagulometers market is being driven by a rise in the incidence and prevalence of blood disorders such as hemophilia that is fueling the demand for more diagnostic tools.
Read More
11 Jan 2022
Medlab Middle East to Return as Standalone Event in 2023
Informa Markets (London, UK), organizers of Medlab Middle East, have announced that the MENA region’s leading exhibition for the laboratory industry will return to a standalone event in 2023.
Read More
Copyright © 2000-2022 All rights reserved. | Terms And Conditions